טיפול מדויק וממוקד בסרטן
Treatment - Clinial Trial
.png){kind=logo}
Alpha DaRT is a groundbreaking technology that enables the use of alpha radiation in a localized treatment of cancer. Our previous research has shown more than 75% complete response rate and no harsh side effects.
Having received FDA’s Breakthrough Device Designation for the treatment of SCC of the skin without curative standard of care, the Alpha DaRT is now available in a skin cancer clinical trial in major medical institutions throughout the US.
This procedure involves:
Minimal invasiveness
No costs for enrolled patients
> 75% complete response*
One time treatment (1-2h)
Local anesthesia
No significant side effects*
*based on previous published studies
Alpha DaRT is administered by inserting thin sources emitting alpha radiation directly into the tumor.
The entire process lasts only 2 weeks plus follow-up visits. The sources are usually removed from the tumor after this period, based on the judgment of the medical staff.
Participating Doctors
Dr. Noam VanderWalde
Radiation Oncologist
West Cancer Center, Memphis TN
Dr. Mark D'Andrea
Radiation Oncologist
University
Cancer & Diagnostic Center, Houston TX
Dr. Arshin Sheybani
Radiation Oncologist
UnityPoint Health, Des Moines, IA
Dr. Elie Levy
Dermatologist
Dermatology of Seattle & Bellevue, Seattle WA
Relevant types of cancers
Irrelevant tumor locations
✓ SCC (Squamous Cell Carcinoma)
✓ Recurrent
✓ Non metastatic
✓ Previously treated tumor
✖ Throat
✖ Brain
✖ Tumors located in internal organs (eg, pancreas, stomach, esophagus, cervix, etc)
✖ Oral cavity
Relevant tumor locations
✓ Cheek (external)
✓ Ear
✓ Nose
✓ Forehead
✓ Skull
✓ Limbs (hands, feet)
✓ Fingers
✓ Scalp
Alpha DaRT Technology
Alpha particles are known to be very destructive to cells. They cause direct damage to the DNA of malignant cells and destroy them. However, the range of alpha particles in tissue is limited. Therefore, until now, it was not possible to use alpha particles as a treatment for solid tumors.
The Alpha DaRT technology uses the diffusion of atoms that emit alpha particles within the tumor tissue, in order to overcome the limitation of their short range. This makes possible the treatment of entire tumors.
The Alpha DaRT technology is based on small amounts of radioactive radium-224 fixed to metal sources that are inserted into the tumor itself.
When Radium-224 decays, it releases radioactive atoms with short lifespans that diffuse inside the tumor. These atoms emit short-range alpha radiation that damages and kills cancer cells within a short period of time. The sources with radium are placed into the tumor with the help of a piece of thread, which is also used to remove them at the termination of treatment.
